Cirino Botta

4.0k total citations
89 papers, 2.1k citations indexed

About

Cirino Botta is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Cirino Botta has authored 89 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 33 papers in Molecular Biology and 29 papers in Hematology. Recurrent topics in Cirino Botta's work include Cancer Immunotherapy and Biomarkers (25 papers), Multiple Myeloma Research and Treatments (24 papers) and Colorectal Cancer Treatments and Studies (14 papers). Cirino Botta is often cited by papers focused on Cancer Immunotherapy and Biomarkers (25 papers), Multiple Myeloma Research and Treatments (24 papers) and Colorectal Cancer Treatments and Studies (14 papers). Cirino Botta collaborates with scholars based in Italy, United States and Spain. Cirino Botta's co-authors include Pierfrancesco Tassone, Pierosandro Tagliaferri, Pierpaolo Correale, Marco Rossi, Nicola Amodio, Maria Teresa Di Martino, Michele Caraglia, Maria Rita Pitari, Domenico Ciliberto and Pierosandro Tagliaferri and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Cirino Botta

83 papers receiving 2.1k citations

Peers

Cirino Botta
Mohan Brahmandam United States
Yinghui Guan China
Els Van Valckenborgh Belgium
Robert L. Cohen United States
Silvia Monestiroli Italy
Maria Teresa Masucci Italy
Flavia Pichiorri United States
Pia Ragno Italy
Luciano Cascione Switzerland
Mohan Brahmandam United States
Cirino Botta
Citations per year, relative to Cirino Botta Cirino Botta (= 1×) peers Mohan Brahmandam

Countries citing papers authored by Cirino Botta

Since Specialization
Citations

This map shows the geographic impact of Cirino Botta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cirino Botta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cirino Botta more than expected).

Fields of papers citing papers by Cirino Botta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cirino Botta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cirino Botta. The network helps show where Cirino Botta may publish in the future.

Co-authorship network of co-authors of Cirino Botta

This figure shows the co-authorship network connecting the top 25 collaborators of Cirino Botta. A scholar is included among the top collaborators of Cirino Botta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cirino Botta. Cirino Botta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiarenza, Annalisa, Nunziatina Laura Parrinello, Anna Maria Corsale, et al.. (2025). BNT162b2 mRNA vaccination affects the gut microbiome composition of patients with follicular lymphoma and chronic lymphocytic leukemia. Biomarker Research. 13(1). 25–25. 1 indexed citations
2.
Fabro, Vittorio Del, Nunziatina Laura Parrinello, Alessandro Allegra, et al.. (2023). Multiple Myeloma in 2023 Ways: From Trials to Real Life. Current Oncology. 30(11). 9710–9733. 8 indexed citations
3.
Corsale, Anna Maria, Nadia Caccamo, Serena Meraviglia, et al.. (2023). Ferritin Metabolism Reflects Multiple Myeloma Microenvironment and Predicts Patient Outcome. International Journal of Molecular Sciences. 24(10). 8852–8852. 6 indexed citations
4.
Corsale, Anna Maria, Melania Carlisi, Nadia Caccamo, et al.. (2023). Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again. SHILAP Revista de lepidopterología. 15(1). 23–49. 2 indexed citations
5.
Manna, Marco Pio La, et al.. (2023). B-Cell Receptor Signaling Is Thought to Be a Bridge between Primary Sjogren Syndrome and Diffuse Large B-Cell Lymphoma. International Journal of Molecular Sciences. 24(9). 8385–8385. 3 indexed citations
6.
Vigna, Ernesto, Daniele Caracciolo, Enrica Antonia Martino, et al.. (2022). Case of Geotrichum capitatum septicemia successfully resolved by the use of liposomal amphotericin B in a patient with acute myeloid leukemia. Journal of Clinical Images and Medical Case Reports. 3(1). 1 indexed citations
7.
Gullà, Annamaria, Eugenio Morelli, Mehmet Samur, et al.. (2021). Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation. Blood Cancer Discovery. 2(5). 468–483. 92 indexed citations
8.
Botta, Cirino, Francesco Mendicino, Enrica Antonia Martino, et al.. (2021). Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities. Cancers. 13(13). 3213–3213. 23 indexed citations
9.
Biamonte, Flavia, Cirino Botta, Maria Mazzitelli, et al.. (2021). Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility. Journal of Translational Medicine. 19(1). 79–79. 25 indexed citations
10.
Morabito, Fortunato, Anna Grazia Recchia, Ernesto Vigna, et al.. (2019). An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma. Expert Opinion on Pharmacotherapy. 21(1). 29–38. 3 indexed citations
11.
Amodio, Nicola, Maria Eugenia Gallo Cantafio, Cirino Botta, et al.. (2019). Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma. Cancers. 11(2). 236–236. 35 indexed citations
12.
Cantafio, Maria Eugenia Gallo, Maria Anna Siciliano, Caterina Riillo, et al.. (2019). Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. Journal of Hematology & Oncology. 12(1). 32–32. 33 indexed citations
13.
Rossi, Marco, Emanuela Altomare, Nicola Amodio, et al.. (2017). Th17 Cells Targeting By MiR-21 Inhibitor Impairs Multiple Myeloma Related Bone Disease. Blood. 130. 4380–4380. 2 indexed citations
14.
15.
Gullà, Annamaria, Maria Teresa Di Martino, Maria Eugenia Gallo Cantafio, et al.. (2015). A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells. Clinical Cancer Research. 22(5). 1222–1233. 97 indexed citations
16.
Morelli, Eugenio, Emanuela Leone, Maria Eugenia Gallo Cantafio, et al.. (2015). Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo. Leukemia. 29(11). 2173–2183. 93 indexed citations
17.
Staropoli, Nicoletta, Domenico Ciliberto, Cirino Botta, et al.. (2013). A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?. Journal of Ovarian Research. 6(1). 10–10. 8 indexed citations
18.
Botta, Cirino, Vito Barbieri, Domenico Ciliberto, et al.. (2013). Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients. Cancer Biology & Therapy. 14(6). 469–475. 75 indexed citations
19.
Ciliberto, Domenico, Cirino Botta, Pierpaolo Correale, et al.. (2012). Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: A meta-analysis of randomised trials. European Journal of Cancer. 49(3). 593–603. 101 indexed citations
20.
Rossi, Marco, Maria Rita Pitari, Nicola Amodio, et al.. (2012). miR‐29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma‐related bone disease. Journal of Cellular Physiology. 228(7). 1506–1515. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohan Brahmandam Breakdown of academic impact, for papers by Yinghui Guan Breakdown of academic impact, for papers by Els Van Valckenborgh Breakdown of academic impact, for papers by Robert L. Cohen Breakdown of academic impact, for papers by Silvia Monestiroli Breakdown of academic impact, for papers by Maria Teresa Masucci Breakdown of academic impact, for papers by Flavia Pichiorri Breakdown of academic impact, for papers by Pia Ragno Breakdown of academic impact, for papers by Luciano Cascione
Rankless by CCL
2026